MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Does Physical Activity impact Resting State Functional Connectivity in Parkinson Disease Patients?

    R. Guimarães, A. Vieira, B. Campos, L. Piovesana, P. Azevedo, J. Zuiani, A. D'Abreu, F. Cendes (Campinas, Brazil)

    Objective: This study aimed to analyze the impact of physical activity practice among PD patients thought resting-state functional magnetic resonance imaging Background: The physiopathology of…
  • 2019 International Congress

    Neural correlates of compensatory process and impaired working memory in Parkinson’s disease during disease progression

    T. Hattori, R. Reynolds, S. Horovitz, G. Chen, C. Lungu, E. Wassermann, M. Hallett (Tokyo, Japan)

    Objective: We aimed to elucidate neural responses associated with working memory (WM) tasks in Parkinson's disease (PD) patients during disease progression. Background: PD patients often…
  • 2019 International Congress

    Measuring disease progression with neuroimaging in MSA-a systematic review

    B. Heim, F. Krismer, W. Poewe, K. Seppi (Innsbruck, Austria)

    Objective: To assess longitudinal changes of serial neuroimaging-derived parameters in MSA. Background: Different neuroimaging modalities hold potential as surrogate markers of neurodegeneration in multiple system…
  • 2019 International Congress

    Imaging Brain Insulin Resistance in Parkinson’s Disease using [¹⁸F]FDG-PET

    E. Hogg, P. Linesch, T. Wu, E. Tan, Z. Fan, W. Gao, A. Waxman, M. Tagliati (Los Angeles, CA, USA)

    Objective: To obtain a glucose brain uptake survey of Parkinson's Disease (PD) patients with or without insulin resistance (IR). Background: IR is common in PD…
  • 2019 International Congress

    Cortical and subcortical atrophy in typical and variant Parkinson-plus syndromes: PROSPECT-M-UK study

    N. Holland, S. Jones, J. Woodside, E. Jabbari, V. Chelban, A. Costantini, PN. Leigh, D. Burn, N. Pavese, A. Gerhard, C. Kobylecki, M. Hu, A. Church, J. Rohrer, H. Houlden, H. Morris, J. Rowe (Cambridge, United Kingdom)

    Objective: To investigate grey matter volume in typical and variant Parkinson-plus syndromes, to correlate these with disease severity, and to assess regional atrophy within disease…
  • 2019 International Congress

    No link between striatal dopaminergic axons and dopamine transporter imaging in Parkinson’s disease

    E. Honkanen, L. Saari, K. Orte, M. Gardberg, T. Noponen, J. Joutsa, V. Kaasinen (Turku, Finland)

    Objective: The objective of this study was to investigate if dopamine transporter (DAT) binding is associated with dopaminergic neurites in the putamen. Background: Dopamine transporter…
  • 2019 International Congress

    Association of MRI-derived estimated brain age and cognitive ability in Parkinson’s disease

    K-L. Horne, R. Shoorangiz, L. Livingston, S. Grenfell, M. Almuqbel, B. Young, M. Pascoe, M. Livingstone, M. Macaskill, D. Myall, T. Pitcher, T. Anderson, J. Dalrymple-Alford, T. Melzer (Chrsitchurch, New Zealand)

    Objective: To characterise MRI-derived structural age-related brain health in Parkinson’s disease (PD) patients as a function of cognitive ability. Background: Normal ageing produces a stereotypical…
  • 2019 International Congress

    “Brain-first” vs. “body-first” Parkinson’s disease is determined by RBD-status – a multi-modality imaging study

    J. Horsager, K. Knudsen, K. Andersen, C. Skjærbæk, T. Fedorova, J. Geday, J. Kraft, E. Bech, E. Danielsen, M. Møller, N. Pavese, D. Brooks, P. Borghammer (Aarhus N, Denmark)

    Objective: In a multi-modality imaging study, we test the hypothesis that Parkinson’s disease (PD) can be divided into two strikingly distinct phenotypes: (1) PD patients,…
  • 2019 International Congress

    Association between sleep disturbances in Parkinson’s disease and bioimaging

    M. Nagai, T. Tsujii, R. Ando, Y. Yamanishi, S. Tada, Y. Hosokawa (Ehime, Japan)

    Objective: We investigated whether bioimaging for Parkinson’s disease (PD) such as metaiodobenzylguanidine (MIBG) myocardial scintigraphy and 123I-ioflupane SPECT (DaTSPECT) are useful for biomarker of sleep…
  • 2019 International Congress

    Primary disruption of the subsystems of the default mode network in drug-naïve Parkinson’s disease with mild cognitive impairments: a resting-state functional connectivity MRI study

    YB. Hou, QQ. Wei, RW. Ou, J. Yang, W. Song, QY. Gong, HF. Shang (Chengdu, China)

    Objective: To study changes in subsystems in drug-naïve Parkinson’s disease with mild cognitive impairments using resting-state functional connectivity MRI. Background: Mild cognitive impairment (MCI) is common…
  • « Previous Page
  • 1
  • …
  • 1392
  • 1393
  • 1394
  • 1395
  • 1396
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley